News

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its phase 3 trial.
Plus, we take an in-depth look at another possible weight loss solution for patients who’ve tried other methods and failed.
Novo Nordisk ended a short-lived agreement to sell its Wegovy weight-loss drug through Hims & Hers Health on Monday, sending ...
Drugmaker Novo Nordisk said it is halting its agreement with telehealth company Hims & Hers after less than two months, ...
Novo Nordisk presented trial results from its trials evaluating the efficacy of CagriSema, another weight-loss drug. Patients ...
Meanwhile, Novo had agreed supply deals with Hims and several of its bigger rivals. The idea was to give their existing ...
Considered a disease of middle-aged and older adults until the late 20th century, type 2 diabetes has risen markedly ...
Novo Nordisk alleged that some telehealth entities, including Hims & Hers, used illicit semaglutide sourced from unregulated ...
Longtime UFC champion Jon Jones is widely considered the GOAT of mixed martial arts but he retires with a complicated legacy.
The buy-back clause is the lifeline. More than €60 million, as reported, is a hefty fee, but it ensures Liverpool maintain a ...